Table 2.
Species, strain, number of animals | Exposure duration, chemical form, route | NaF concentration in DW (mg/L) |
Doses (mg/kg/d) | NOAEL (mg/L) (mg/kg/d) |
LOAEL (mg/L) (mg/kg/d) |
Outcome (as stated by the authors) | Comments | References |
---|---|---|---|---|---|---|---|---|
Rat, CD, 26/group |
GD 6 through 15 Investigations were done on GD 20 Sodium fluoride (DW) |
< 0.6, 50, 150, 300 | NaFa: 0, 6.6, 18.3, 27.1 |
≥ 300 mg/L NaF 27 mg NaF/kg/da |
– | Maternal exposure to NaF during organogenesis did not significantly affect the frequency of postimplantation loss, mean fetal body weight/litter, or external, visceral or skeletal malformations |
NOAEL is the highest dose tested Drinking water: < 0.6 mg/L NaF Feed: 12.4 mg per kg fluoride |
Heindel et al. (1996) |
Total F– intake (water and feed)a: 1, 4.0, 9.3, 13.2 | 13.2 mg F– /kg/da | |||||||
Rabbit, New Zealand White rabbits, 26/group |
GD 6 through 19 Investigations were done on GD 30 Sodium fluoride (DW) |
< 0.6, 100, 200, 400 | NaFa: 0, 10.3, 18.1, 29.2 |
≥ 400 mg/L NaF 29 mg NaF/kg/da |
– | Maternal exposure to NaF during organogenesis did not significantly affect the frequency of postimplantation loss, mean fetal body weight/litter, or external, visceral or skeletal malformations |
NOAEL is the highest dose tested Drinking water: < 0.6 mg/L NaF Feed: 15.6 mg per kg fluoride |
Heindel et al. (1996) |
Total F– intake (water and feed)a: 0.8, 5.8, 8.8, 13.7 | 13.7 mg F– /kg/da | |||||||
Rat, CD, 35–37/group |
GD 0 through GD 20 Investigations were done on GD 20 Sodium fluoride (DW) |
0, 10, 25, 100, 175, 250 | NaFa: 0, 1.4, 3.9, 15.6, 24.7, 25.1 |
175 mg/L NaF 24.7 mg NaF/kg/da |
250 mg/L 25.1 mg NaF/kg/da |
Fetal growth, number of external anomalies in fetuses, development of specific bones, including sternebrae were not affected by NaF A significant increase in the average number of fetuses with three or more skeletal variations was observed in the 250 mg/L group The number of litters with fetuses with three or more skeletal variations was increased in the 250 mg/L group (not statistically significant) |
Water consumption in the 175- and 250-mg/L groups was significantly less than that of the control females. The daily amount of NaF ingested was less than expected at the two higher dose levels Feed: 7.95 mg/kg fluoride Control: Aqua Cool Ultra Pure water |
Collins et al. (1995) |
F–a: 0, 0.6, 1.8, 7.1, 11.2, 11.4 | 11.2 mg F– /kg/da | 11.4 mg F– /kg/da | ||||||
Rat, CD, 48/sex/group |
Continuously during three generations. F0 rats were treated for 10 weeks and mated within groups Investigations of F0, F1 and F2 fetuses were done on GD 20 Sodium fluoride (DW) |
0, 25, 100, 175 or 250 | NaFa: 0, 3.4, 12.4–13.2, 18.8–19.3, 25.8–28.0 |
175 mg/L NaF 18.8–19.3 mg NaF/kg/d |
250 mg/L NaF 25.8–28.0 mg NaF/kg/d |
Sodium fluoride in drinking water at 175 mg/L produced no compound-related effects. Numbers of corpora lutea, implants, viable fetuses and fetal morphological development were similar in all groups. No dose-related anomalies in internal organs were observed in F2 fetuses Ossification of the hyoid bone of F2 fetuses was significantly decreased at 250 mg/L (considered as LOAEL) |
Feed: 7.95 mg/kg fluoride Concentration of fluoride in the Pico system treated water: < 0.2 mg/L |
Collins et al. (2001b) |
F–a: 0, 1.5, 5.6–6.0, 8.5–8-7, 11.7–12.7 | 8.5–8.7 mg F– /kg/d | 11.7–12.7 mg F– /kg/d |
DW drinking water, GD gestation day, NaF sodium fluoride
aAs reported by the authors of the study